ISSN 1866-8836
Клеточная терапия и трансплантация

Stromal-hematopoietic interrelationships: Maximov's ideas and modern models

A. Friedenstein

doi 10.3205/ctt-2009-en-000033.01


Republished from Modern Trends in Human Leukemia VIII (1989),
Ed. R. Neth, with kind permission by Springer Science and Business Media.

The idea of stromal-hematopoietic cell interactions was the essential part of Alexander Maximov's theory of hematopoiesis, which he proposed more than 60 years ago. According to Maximov (see Figs. 1-4), committed hematopoietic precursors descend from the hematopoietic stem cells due to local impacts generated by marrow stroma; this creates the conditions for hematopoietic cell differentiation [1]. Maximov's theory was far ahead of his time, and, though Maximov was highly respected in the scientific community, his concept of local "differentiation conditions" operative in hematopoiesis was met with particular skepticism. Today, Maximov's idea raises no doubt; in fact, it constitutes the essence of the problem of hematopoietic microenvironment (HME). What provokes discussions in modern hematology is the exact types of stromal cells responsible for HME and the mechanisms of stromal-hematopoietic cell interactions. Maximov assumed that the stromal cells in question were stromal fibroblasts (reticular cells), but for a long time many experimental hematologists denied this. Only recently has it been possible to apply two experimental models for checking the microenvironmental functions of marrow fibroblasts. The first model is the transfer of HME by heterotopic transplantation of marrow cells; the sccond is the establishment of HME in vitro by stromal cell underlayers in Dexter cultures. 

Heterotopic transplantation of marrow cells results in the formation of marrow organs covered by a bone capsule [2-5]. Their hematopoietic cells are of the recipient origin [6], indicating that engraftment of some category of marrow cells results in the formation of bone and an HME suitable for population by hematopoietic cells and for their proliferation and differentiation. Heterotopic marrow can be retransplanted repeatedly with similar results, provided the recipients are compatible with H-2 antigens of the initial donor, not of the intermediate recipients [7, 8]. This means that HME is transferred by engraftment of the marrow cells which remain unreplaced by the recipient cells. Chromosome typing of clonogenic stromal fibroblasts (CFUf) of the heterotopic marrow confirmed their donor origin [9, 10], and the problem was to check whether stromal fibroblasts were able to transfer HME when grafted heterotopically.

The in vitro descendents of CFUf after several passages compose diploid fibroblast culturcs [11-13]. Tested by heterotopic transplantation, they were found to form bone marrow organs, while engraftment of cultured spleen fibroblasts (the descendents of spleen CFUf) produced lymphoid organs [14, 15]. Thus, cultured marrow fibroblasts appear to be able to transfer bone marrow HME. Depending on the origin of marrow fibroblast cultures (the source CFUf being from red or yellow marrow), their engraftment transferred not only the general pattern of HME, but also such details as the density of hematopoietic cells in a would-be marrow [16].

Cultured marrow fibroblasts produce hematopoietic growth factor (M-CSF, G CFS, GM-CFS, BFUf- and mixed-colony-CSF) which can be detected in the culture medium [17-20]. They regulate proliferation and differentiation of GMCFU: their stimulatory effects were noted when the target marrow contained few spontaneous colonies, the inhibitory effects when large numbers of spontaneous GM-CFU were present [21]. Hematopoietic growth factors are also produced by cloned lines of marrow fibroblasts [22]. However, the direct proof of in vitro microenvironmental competence of marrow fibroblasts was their ability to establish HME in Dexter-type cultures. It has been shown [23] that when used as underlayers, the passaged murine marrow fibroblasts, free from macro phages and endothelial cells, supported hematopoiesis if seeded with stromal cell-depleted marrow suspensions.

Thus, cultured marrow fibroblasts transfer HME, release hematopoietic growth factors in vitro, and are capable of presenting them in a proper way to support hematopoiesis in cultures. This confirms Maximov's hypothesis of the role of marrow fibroblasts in hematopoiesis.

The population of marrow fibroblasts is probably a heterogeneous one, and there is no evidence that marrow fibroblasts which produce or present hematopoietic growth factors are the same cells which transfer HME, and vice versa. It may well be that there are several subpopulations of marrow fibroblasts with different microenvironmental functions. At present, fibroblasts including those from nonhematopoietic and hematopoietic organs look much alike, reminiscent of the situation with lymphocytes in Maximov's time. The main and most conclusive sine of fibroblasts (mechanocytes) is interstitial collagen types I and III synthesis, and few markers of their phenotype and genetic diversity have been so far ascertained. The diversity does exist, for instance, between marrow as compared with spleen fibroblasts, which is proved by the results of their heterotopic transplantation. The next question regarding HME seems to be the diversity of marrow fibroblasts including their clonogenic precursor cells.

In primary cultures of marrow cell suspensions the CFUf (CFCf) form adherent-cell colonies which are cell clones [24, 25]. The colonies are composed of fibroblasts which synthesize type-I and -III collagen and fibronectin and lack macrophage markers and VIII-factor-associated antigen [26-30]. Morphologically, the colonies are distinctly heterogeneous within each culture. Some are composed of elongated or blanket-like fibroblasts or of a mixture of both; the colonies may include fat cells or have a mineralized intercellular matrix [39]. These differences can hardly be regarded as markers of CFCf, the diversity not beeing stable at passaging and recloning.

In situ CFCf are outside the cycle arrested in G0 [31]. Marrow fibroblasts possess PDGF receptors [32] and in medium with platelet-poor plasma their proliferation and the CFUf colony formation requires PDGF [34]. It is believed that serum growth factors, which include PDGF, are sufficient for recruitment of CFCf into the cycle and that CFUf colony formation in serum-supplemented medium does not require additional growth stimulation. Yet this is probably not the case.

The efficiency of CFUf colony formation (CFEf) drops close to zero in low-density marrow cultures if they are depleted of nonadherent cells: 85% of CFCf do not proliferate at all or pass through one to three cell doublings (Fig. 1). On the other hand, the CFEf increases dramatically when such adherent marrow cell cultures are supplemented with irradiated marrow feeder cells or with platelets. This colony-stimulating activity is not replaced by additional PDGF and is expressed only in the serum-rich medium. Being stimulated by platelets each fibroblast precursor present in marrow cell suspensions turns out to be a clonogenic stromal cell (Fig. 1).


Figure 1. CFUf colony formation in mice adherent marrow cell cultures.
Cultures were initiated by injecting 5×105 mechanically (white columns) or 5×104 trypzinised (black columns) marrow cells per culture flask (25 cm2). Two hours after explantation the nonadherent cells were decanted from all cultures and further cultivation accomplished in aMEM medium plus 20% embryonal calf serum, part of the cultures (G) being additionally suplemented with 107 irradiated (60 Gy) marrow cells. Abscissa: A - E - fibroblast foci, fibroblast colonies and single fibroblasts in feeder non-supplemented cultures. A - single fibroblasts in one day cultures; B - F - 10 day cultures. B - single fibroblasts, C - two fibroblasts foci, D - three-eight fibroblasts foci, E - nine-forty nine fibroblasts foci, F - fibroblast colonies composed of 50 and more fibroblasts, Σ-sum of B, C, D, E and F per culture. G - fibroblasts colonies in 10 days feeder-supplemented cultures. Ordinate: mean numbers (M ± m) of single fibroblasts, fibroblast foci and fibroblast colonies for 3-5 cultures.

Thus, nonstromal marrow cells which accompany CFCf in marrow cultures (probably megakaryocytes) provide growth-stimulating factors for CFUf colony formation. There are indications that CFCf are sensitive also to other growth-stimulating factors which induce the formation of fibroblast colonies with a different composition of matrix proteins. It has been reported [35] that marrow cells cultured in methylcelluloseclotted plasma with cortisone and PHA-stimulated leukocyte-conditioned medium produced fibroblast colonies with collagen type IV and laminin, in addition to collagen types I and III and fibronectin present in CFUf colonies, in liquid cultures with the serum-supplemented medium. The differences suggest either that there is a diversity of CFCf, which also require different colony-stillulating factors, or that the same CFCf can generate different descendents, depending on the stimulating factors used to induce colony formation.

Marrow CFCf diversity was demonstrated with regard to their proliferative and differentiative potencies. Only a small portion (10%) of single CFUf colonies transferred HME when grafted heterotopically, i. e., formed bone marrow organs [36]. At least 30% of CFCf appeared to be highly proliferative cells which provide single-colony-derived fibroblast cultures with 20-30 population doublings. When tested by transplantation of cells in diffusion chambers, 20% of these cultures formed simultaneously bone, cartilage, and reticular-like tissue, 30% formed only bone, and 27% only reticular-like tissue. The number of osteogenic units in late passages of cultured fibroblasts exeeded by far the total numbers of the initially explanted marrow cells, indicating that osteogenic precursors intensively multiplied within cultures [37]. There are reasons to consider CFCf with osteochondrogenic potencies as being osteogenic stem cells [38, 39]. One can assume that some of them are the progenitors of a marrow stromallineage which includes committed osteogenic precursors, mature bone cells, and microenvironmentally competent fibroblasts (reticular cells).


Figure 2. Type I collagen in 12 day CFUf colony of guinea pig periferal blood leukocytes.

A. Anticollagen antiserum, immunoperoxidase reaction


B. Live culture

The assumption is backed up by the obligatory association of HME transfer with bone formation, which applies to heterotopic transplantation of both freshly isolated marrow and single-CFUf-derived fibroblast colonies. In the heterotopic marrow the CFUf are of donor origin [9, 10], and it is reasonable to assume that the same applies to the microenvironmentally competent reticular cells. However, the ability of fibroblasts from single CFUf-colony-derived heterotopic bone marrow organs to support hematopoiesis in vitro, and their donor origin (which would be the proof of the above speculation) was not tested up to now. Anyway, the hierarchy of marrow precursors awaits further studies.

As far as Maximow's contribution to the problems of HME is concerned, it is impossible to omit his last work, entitled "Cultures of blood leukocytes. From lymphocyte and monocyte to connective tissue." [40]. It describes the formation of fibroblasts in plasma-clot cultures of guinea-pig blood cells. Subsequently, his results were put in question on the grounds of two possible objections, namely that the source of fibroblasts might be fragments of vessel walls which contaminate the blood during sampling, and that the cells in question were not fibroblasts (for references, see [41]).

Figure 3 A, B. Fibroblasts and collagen fibrils in 16 day CTUf colonies of rabbit periferal blood leukocytes. E. M.




Figure 4. Professor Alexander Maximov

The first objection proved to be invalid when a CFUf colony assay was carried out with blood cells. It turned out that the incidence of CFUf colonies in guinea-pig and rabbit leukocyte cultures did not change with the number of punctures performed for blood sampling [42]. It has also been shown that fibroblasts in blood-derived CFUf colonies synthesize collagen type I [43] and lack VIII-factor-associated antigen and macrophage determinant MacI [44], which confirms their fibroblast nature (Fig. 2, 3). It remains unknown from where CFUf migrate into blood, where they settle (if they do), and why blood-derived CFUf are not detectable in some mammals, including human beings. The presence of fibroblast precursors in blood discovered by Maximov is related to many unsolved problems of HME, in particular, to the possibility of CFUf repopulation; CFUf circulation in blood does not prove it at all.

The story of the circulating fibroblast precursor cells demonstrates once again that not only Maximov's ideas, but also his experimental results are so topical that Professor Alexander Maximov almost remains a participant of present-day research (Fig. 5).


Figure 5. Maximov in his tissue culture laboratory in the Military Medical Academy in Petersburg (1915).

A. Preparation of plasma for plasma-clot cultures


B. Placing tissue fragments in culture medium


C. Kaissug hangrug-drop cultures in hallow-ground microscope slides


1. Maximov AA. Über experimentelle Erzeugung von Knochenmarks-Gewebe. Anat Anz. 1906;28:24-38.

2. Tavassoli M, Crosby WH. Transplantation of marrow to extramedullary sites. Science. 1968;161:54-56.

3. Tavassoli M, Maniatis A, Binder RA, Crosby WH. Studies on marrow histogenesis. Proc Soc exp BioI Med. 1971;138:868-870.

4. Tavassoli M, Friedenstein A. Hemopoietic stromal microenvironment. Am J Hemat. 1983;15:195-203.

5. Friedenstein AJ, Latzinik NV, Grosheva AO, Gorskaya UF. Marrow microenvironment transfer by heterotopic transplantation of freshly isolated and cultured marrow cells in porous sponges. Exp Hematol. 1982;10:217-227.

6. Friedenstein AJ, Petrakova KV, Kuralesova AI, Frolova OF. Heterotopic transplants of bone marrow. Analysis of precursor cells for osteogenic and hemopoietic tissues. Transplantation. 1968;6:230-247.

7. Friedenstein AJ, Kuralesova A. Osteogenic precursors of bone marrow in radiation chimeras. Transplantation. 1971;12:99-108.

8. Friedenstein A, Luria E. Cellular bases of hemopoietic microenvironment. Moscow: Izd-vo "Medicina"; 1980. Russian.

9. Friedenstein A, et al. Origin of bone marrow stromal mechanocytes in radiochimeras and in heterotopic transplants. Exper Hematol. 1978;6:440-444.

10. Friedenstein A. Precursor cells of mechanocytes. Inter Rev Cytol. 1976;47:327-359.

11. Friedenstein A, Chailakhjan RV, Lalykina KS. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet. 1970;3:393-403.

12. Miskarova ED, Lalykina KS, Kokorin IN, Friedenstein AJ. Osteogenic potencies of prolonged diploid cultures of myeloid cells. Bull Exp BioI Med. 1970;56:78-81.

13. Friedenstein A. Determined and inducible osteogenic precursor cells. Ciba Found Sympos (new series). 1973;11:170-185.

14. Friedenstein AJ, et al. Stromal cells responsible for transferring the microenvironment of hemopoietic tissues. Cloning in vitro and retransplantation in vivo. Transplantation. 1974;17:331-340.

15. Friedenstein A. Stromal mechanocytes of bone marrow: cloning in vitro and retransplantation in vivo. In: Thierfelder S, Rodt H, Kolb H (eds). Immunology of bone marrow transplantation. Springer-Verlag. 1980;19-29.

16. Patt HM, Maloney MA, Flannery ML. Hemopoietic microenvironment transfer by stromal fibroblasts derived from bone marrow varying in cellularity. Exp Hematol. 1982;10:738-742.

17. Akasaka M, et al. Production of monoclonal antibody to adult bone marrow preadipocite line (H-I/A). Exp Hematol. 1987;15:610-618.

18. Brockbank K, Van Peer CM. Colony-stimulating activity produced by hemopoietic organ fibroblastoid cells in vitro. Acta Hematol. 1983;69:369-476.

19. Zucali J, et al. Interleukin I stimulates fibroblasts to produce granulocyte macrophage colony-stimulating activity and prostoglandin E2. J Clin Invest. 1986;78:1306-1323.

20. Lee M, Segal GM, Bagby GC. Interleukin I induces human bone marrow-derived fibroblasts to produce multilineage hemopoietic growth factors. Exper Hematol. 1987;15:983-988.

21. Brondy V, et al. Monocytes stimulate fibroblastoid bone marrow stromal cells to produce multilineage hemopoietic growth factors. Blood. 1986;68:530-537.

22. Greenberger BR, Wilson FD, Woo L. Granulopoetic effects of human bone marrow fibroblastic cells and abnormalities in "granulopoietic microenvironment". Blood. 1981;58:557-563.

23. Brockbank KCM, De Jong JP, Piersma AH, Voerman JSA. Hemopoiesis on purified bone-marrow-derived reticular fibroblasts in vitro. Exper Hematol. 1986;14:386-394.

24. Latzinik N, et al. The content of stromal colony-forming cells (FCFC) in the mousebone marrow and the clonal nature of  FCFC-derived fibroblast colonies. Ontogenesis. 1986;1:27-35.

25. Friedenstein A, et al. On clonality of CFUf-derived marrow stromal colonies (in press). [1989].

26. Latzinik NV, Sidorovich SY, Tarchanova IA. Studies of surface receptors of the stromal mechanocytes of hemopoietic organs. Immunology. 1980;1:26-28.

27. Castro-Malaspina H, et al. Characterization of human bone marrow fibroblast colony-forming cells (CFUf) and their progeny. Blood. 1980;56:286-301.

28. Wilson FD, O'Grady L, Mc Meil GJ, Munn SL. The formation bone marrow-derived fibroblastic plaques in vitro. Exper Hematol. 1974;2:343-349.

29. Friedenstein A, et al. Precursors for fibroblasts in different populations of hemopoietic cells as detected by the in vitro colony assay method. Exper Hematol. 1974;2:83-92.

30. Friedenstein AJ, Gorskaya UF, Kulagina NN. Fibroblast precursors in normal and irradiated mouse hemopoietic organs. Exper Hematol. 1976;4:267-274.

31. Keilis-Borok IV, Latzinik NV, Epichina SY, Friedenstein AJ. Dynamics of the formation of fibroblast colonies in monolayer cultures of bone marrow, according to 3H-thymidine incorporation experiments. Cytologia. 1971;13:1402-1409.

32. Bowen-Pope DF, Seifert RA, Ross R. The platelet-derived growth factor receptor. In: Boyton L, Leffert H (eds). Control of animal cell proliferation, Acad Press. 1985;1:281-312.

33. McIntyre AP, Bjornson BH. Human bone marrow stromal cell colonies: response to hydrocortisone and dependence of platelet-derived growth factor. Exper Hematol. 1986;14:833-839.

34. Wang OR, Wolf  NS. The effect of several growth factors on the in vitro growth of bone marrow stromal cells. Exper Hematol. 1987;15:610.

35. Lim B, et al. Characterization of reticulofibroblastoid colonies (CFU-RF) derived from bone marrow and long-term marrow culture monolayers. J Cellul Physiol. 1986;127:45-54.

36. Chailakyan RK, Gerasimov YF, Friedenstein AJ. Content of osteogenic precursor cells in the bone marrow and their proliferation in cultures. Bull Exp Biol Med. 1984;11:605-608.

37. Gerasimov Y, Friedenstein AJ, Chajlakjan RK, Shiskova VV. Differential potentiality of clonal strains of bone marrow fibroblasts. Bull Exp Biol Med. 1986;6:717-719.

38. Friedenstein AJ, Chajlachyan RK, Gerasimov YF. Bone marrow osteogenic stem cells in vitro cultivation and transplantation in diffusion chambers. Cell Tissue Kinet. 1987;20:263-272.

39. Owen ME, Friedenstein AJ. Stromal stem cells: marrow derived osteogenic precursors. In: Evered D, Harnett S. (eds). Cellular and molecular biology of vertebrate hard tissues. Ciba Found Symp. 1988;136:42-52.

40. Maximov A. Cultures of blood leucocytes. From leucocyte and monocyte to connective tissue. Arch exp Zellforsch. 1928;5:169-178.

41. Jacoby F. Macrophages. In: Willmer E (ed). Cells and tissues in culture. Acad Press. 1965;1:1-93.

42. Luria EA, Panasyuk AF, Friedenstein AJ. Fibroblast colony formation from monolayer cultures of blood cells. Transfusion. 1971;11:345-349.

43. Luria E, et al. Colony forming fibroblast precursors in circulating blood. Bull Exp Biol Med (in press). [1989].

44. Piersma AH, Ploemacher RE, Brockbank KG. Migration of fibroblastoid stromal cells in murine blood. Cell Tissue Kinet. 1985;18:589-595.


1. Friedenstein A. Stromal-Hematopoietic Interrelationships: Maximov's Ideas and Modern Models. In: Neth R, et al, editors. Modern trends in human leukemia VIII. Berlin. 1989:159-167.

2. Friedenstein A. Stromal-Hematopoietic Interrelationships: Maximov's Ideas and Modern Models. Haematol. Bluttransf. 1989;32.

Republished from Modern Trends in Human Leukemia VIII (1989), Ed. R. Neth, with kind permission by Springer Science and Business Media.

Volume 1, Number 3

Download PDF version

doi 10.3205/ctt-2009-en-000033.01

Back to the list